Does Ozempic List Heart Palpitations as a Side Effect?
Ozempic (semaglutide) does not commonly cause heart palpitations. Clinical trial data and FDA labeling report tachycardia (increased heart rate) in less than 1% of patients, but isolated palpitations are not a highlighted adverse event.[1][2] Post-marketing reports via FDA's FAERS database include rare mentions of palpitations, often linked to dehydration, low blood sugar, or concurrent conditions rather than the drug directly.[3]
How Common Are Heart-Related Complaints with Ozempic?
In pivotal trials like SUSTAIN, cardiovascular events were monitored closely due to diabetes risks. Ozempic showed a 26% reduction in major adverse cardiovascular events overall, with no increase in arrhythmias or palpitations.[4] Real-world data from over 1 million users echoes this: heart rate increases average 2-3 beats per minute, but symptomatic palpitations affect under 0.5%.[5] Patient forums like Drugs.com note palpitations in anecdotal reviews (about 2% of 1,500+ Ozempic reports), typically mild and transient.[6]
Why Might Someone Feel Palpitations on Ozempic?
Rapid weight loss or gastrointestinal side effects (nausea, vomiting in 15-20% of users) can lead to electrolyte imbalances or dehydration, mimicking palpitations.[2] Hypoglycemia, more common when combined with insulin or sulfonylureas, triggers adrenaline surges causing racing heart.[1] Pre-existing atrial fibrillation or thyroid issues amplify risks; Ozempic carries a boxed warning for thyroid C-cell tumors in rodents, but no human heart rhythm link.[2]
What Do Doctors Recommend if Palpitations Occur?
Consult a doctor immediately—stop Ozempic only under guidance. They may check ECG, electrolytes, or thyroid function. Dose adjustments (start at 0.25 mg weekly) or switching to alternatives like Trulicity reduce GI triggers.[1] Hydration, small meals, and monitoring blood sugar help most cases resolve without discontinuation.[7]
How Does Ozempic Compare to Other GLP-1 Drugs for Heart Effects?
| Drug | Tachycardia Rate | Palpitations Reports | CV Outcome Benefit |
|------|------------------|----------------------|--------------------|
| Ozempic (semaglutide) | <1% | Rare | MACE reduction 26% [4] |
| Wegovy (higher-dose semaglutide) | 1-2% | Low | Similar profile [8] |
| Mounjaro (tirzepatide) | <1% | Similar rarity | Ongoing trials [9] |
| Trulicity (dulaglutide) | 0.5% | Minimal | MACE reduction 12% [10] |
All GLP-1 agonists mildly elevate heart rate but lower overall CV risk in trials.
When to Worry About Serious Heart Issues
Seek emergency care for palpitations with chest pain, dizziness, or fainting—these signal potential arrhythmia or other issues, not uniquely tied to Ozempic.[11] Long-term data (up to 5 years) shows no excess sudden cardiac death.[4] No patents directly cover heart side effects; Ozempic's key patents expire 2031-2032.[12]
Sources
[1]: FDA Ozempic Label
[2]: Novo Nordisk Prescribing Info
[3]: FDA FAERS Database
[4]: SUSTAIN-6 Trial, NEJM
[5]: JAMA Network Open Study
[6]: Drugs.com Reviews
[7]: ADA Guidelines
[8]: FDA Wegovy Label
[9]: SURPASS Trials
[10]: REWIND Trial
[11]: AHA Palpitations Guidance
[12]: DrugPatentWatch: Ozempic